PolyPeptide Group AG (SWX: PPGN)
Switzerland
· Delayed Price · Currency is CHF
32.25
-0.80 (-2.42%)
Sep 4, 2024, 5:30 PM CET
PolyPeptide Group AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | 82.44 | 82.5 | 145.47 | 144.24 | 78.36 | 71.01 | |
Depreciation & Amortization | 0.1 | 0.13 | 0.13 | 0.14 | 0.14 | 0.13 | |
Operating Cash Flow | 42.01 | 81.17 | 4.89 | 33.35 | 45.63 | 36.02 | |
Operating Cash Flow Growth | -24.32% | 1561.56% | -85.35% | -26.93% | 26.68% | 56.10% | |
Investing Cash Flow | -52.67 | -10.19 | 133.68 | 50.22 | 45.83 | 28.54 | |
Long-Term Debt Issued | - | 86.4 | - | 119.82 | 41.25 | 70 | |
Long-Term Debt Repaid | - | -100 | -34 | -156 | -80.1 | -155 | |
Net Debt Issued (Repaid) | 67.7 | -13.6 | -34 | -36.18 | -38.85 | -85 | |
Issuance of Common Stock | - | - | - | - | 11.96 | - | |
Repurchase of Common Stock | - | -0.63 | -36.15 | -1.65 | -1.3 | -54.88 | |
Common Dividends Paid | -50.7 | -92.18 | -47.39 | -47.5 | -46.96 | -41.32 | |
Net Cash Flow | 6.34 | -35.43 | 21.03 | -1.77 | 16.32 | -116.63 | |
Free Cash Flow | 42.01 | 81.17 | 4.89 | 33.35 | 45.63 | 36.02 | |
Free Cash Flow Growth | -24.32% | 1561.56% | -85.35% | -26.93% | 26.68% | 56.10% | |
Free Cash Flow Margin | 44.76% | 47.18% | 2.10% | 17.98% | 38.89% | 37.91% | |
Free Cash Flow Per Share | 4.56 | 8.81 | 0.53 | 3.51 | 4.85 | 3.79 | |
Cash Interest Paid | 6.7 | 7.02 | 6.13 | 7.89 | 9 | 11.64 | |
Cash Income Tax Paid | 5.48 | 19.56 | 43.53 | 32.25 | 9.33 | 16.94 | |
Levered Free Cash Flow | 36.73 | 89.54 | 94.73 | 88.03 | 80.62 | 46.87 | |
Unlevered Free Cash Flow | 40.91 | 93.4 | 98.54 | 93 | 86.2 | 53.07 | |
Change in Net Working Capital | 4.75 | -35.06 | 22.82 | 9.82 | -26.15 | -6.77 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.